JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow A correction has been published
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baum, T.
Right arrow Articles by Bennett, D. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baum, T.
Right arrow Articles by Bennett, D. R.
Journal of Pharmacology And Experimental Therapeutics, Vol. 137, Issue 3, 275-284, 1962
Copyright © 1962 by American Society for Pharmacology and Experimental Therapeutics


THE CARDIOVASCULAR PHARMACOLOGY OF t-BUTYLAMINE

Thomas Baum 1, Kent R. Hornbrook 1, Hector Vasquez-Leon 1, and Donald R. Bennett 1

1 Department of Pharmacology, The University of Michigan Medical Center, Ann Arbor, Michigan

Of the 8 known aliphatic primary amines below n-pentylamine, only isopropylamine has been shown by previous workers to be principally pressor at conparable dose levels; however, t-butylamine was not tested.

This study has shown that t-BA may be classified as a sympathomimetic amine. Positive inotropie and chronotropic actions of t-BA are largely responsible for the pressor response. The cardiac stimulating sites of action of t-BA are peripheral and not central or ganglionic in origin. Varying decreases in total peripheral resistance were observed during the pressor response. Constrictor and dilator responses occur in the Perfused dog hindquarters subsequent to intra-venoums administration of t-BA while the perfused renal bed constricts. These constrictor responses also contribute to the systemic pressor effect.

The cardiac stimulant and vascular constrictor actions of t-BA appear to be mediated via indirect mechanisms, i.e., release and potentiation of catecholamines. The adrenal medulla and heart are two sources of the released material. t-BA appears to be similar to tyramine in its mechanism of cardiac release of amines.

Submitted on June 11, 1962







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1962 by the American Society for Pharmacology and Experimental Therapeutics.